niceritrol has been researched along with eicosapentaenoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hotta, O; Ieiri, N; Taguma, Y | 1 |
| Fujioka, T; Matsumoto, T; Ueno, T; Watanabe, H | 1 |
1 review(s) available for niceritrol and eicosapentaenoic acid
| Article | Year |
|---|---|
[Dyslipidemia in renal failure].
Topics: Arteriosclerosis; Cerebrovascular Disorders; Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Coronary Disease; Eicosapentaenoic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Kidney Failure, Chronic; Lipoproteins, VLDL; Niceritrol; Peripheral Vascular Diseases; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Triglycerides | 2004 |
2 other study(ies) available for niceritrol and eicosapentaenoic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy.
Topics: Adult; Anticholesteremic Agents; Apolipoproteins E; Drug Combinations; Eicosapentaenoic Acid; Female; Fenofibrate; Humans; Hypolipidemic Agents; Kidney Diseases; Kidney Glomerulus; Lipids; Lipoproteins; Male; Microscopy, Electron; Nephrotic Syndrome; Niceritrol; Pedigree; Probucol | 2003 |